We developed a silicon-based biosensor that generates visual, qualitative results or quantitative results for the detection of protein or nucleic acid targets in a multiplex format. Methods: Capture probes were immobilized either passively or covalently on the optically coated surface of the biosensor. Intermolecular interactions of the immobilized capture probe with specific target molecules were transduced into a molecular thin film. Thin films were generated by enzyme-catalyzed deposition in the vicinity of the surface-bound target. The increased thickness on the surface changed the apparent color of the biosensor by altering the interference pattern of reflected light. Results: Cytokine detection was achieved in a 40-min multiplex assay. Detection limits were 4 ng/L for interleukin (IL)-6, 31 ng/L for IL1-␤, and 437 ng/L for interferon-␥. In multianalyte experiments, cytokines were specifically detected with signal-to-noise ratios ranging from 15 to 80. With a modified optical surface, specificity was also demonstrated in a nucleic acid array with unambiguous discrimination of single-base changes in a 15-min assay. For homozygous wild-type and homozygous mutant samples, signal-to-noise ratios of ϳ100 were observed. Heterozygous samples yielded approximately equivalent signals for wild-type and mutant capture probes. Conclusions: The thin-film biosensor allows rapid, sensitive, and specific detection of protein or nucleic acid targets in an array format with results read visually or quantified with a charge-coupled device camera. This biosensor is suited for multianalyte detection in clinical diagnostic assays.
ideal detection platform would be inexpensive, recognize targets rapidly with high sensitivity and specificity, possess high stability, and in many cases, create an interpretable signal without instrumented intervention. We describe here an optically coated, highly reflective, siliconbased surface designed to permit visual detection of biological interactions in white light (1, 2 ) . Specific capture molecules are immobilized on the coated surface. After interaction with specific targets, the addition of an antibody conjugated to horseradish peroxidase (HRP) 1 catalyzes formation of an organic thin film in the presence of a precipitating substrate formulation. The thin film increases the thickness of the surface, producing a visible color change attributable to destructive interference. Film thicknesses on the order of 5 nm are readily detected visually by untrained users. The optical layer composition and thickness are selected on the basis of refractive indices, biomolecule compatibility, and the known sensitivity of the human eye to various color transitions (1, 2 ) .
We previously described rapid, single-analyte biosensors that use thin-film technology for protein assays. Diagnostic targets have included conserved nonstructural proteins in rhinovirus (3 ) and influenza virus (4 ) , and the brain trauma marker S-100B (5 ) . These assays take 6 -20 min to complete with analytical sensitivities equal to a similarly configured ELISA format.
Recently, thin-film technology has been applied to the detection of nucleic acid targets. The nucleic acid biosensor demonstrated a detection limit of 60 000 copies, or 10 fmol/L, for a single-stranded DNA target (6 ) . Using this format, our laboratory developed a test to rapidly and specifically detect the mecA gene in methicillin-resistant Staphylococcus aureus (6, 7 ) . This biosensor also provides a rapid and simple replacement for gel electrophoresis for the detection of multiplex reverse transcription-PCR products from RNA viruses present in respiratory infections (8 ) .
We describe here further applications of the biosensors for simultaneous detection of multiple cytokines and for discrimination of single nucleotide polymorphisms in the human cystic fibrosis transmembrane conductance regulator (CFTR) gene.
assay principle
The base substrate of the thin-film biosensor is a crystalline silicon wafer that provides a highly reflective, chemically inert, flat surface. The surface is coated with silicon nitride (Si 3 N 4 ), which serves as an antireflective optical layer. Si 3 N 4 was chosen as the optical coating because of its ability to be easily applied to silicon by chemical vapor deposition techniques and because it has an appropriate refractive index. A Si 3 N 4 coating of 47.5 nm was necessary to obtain a gold surface color (Fig. 1A) . Although the Si 3 N 4 layer is sufficient for the optical coating, a more biologically compatible layer is required to obtain efficient immobilization of capture moieties. Optimal performance of this attachment layer was obtained with the polymer aminoalkyl functional T-structure polydimethylsiloxane (TSPS), which was applied by spin coating to a thickness of 13.5 nm. The polypeptide poly(phenylalanine-lysine) (PPL) was passively adsorbed onto the TSPS layer. PPL served to provide amino functionality to the surface, allowing the covalent attachment of activated N-hydroxysuccinimide esters of N-terminal-modified oligonucleotides or to improve the efficiency for passive adsorption of proteins.
The thin-film biosensor surface can be coated with capture moieties that recognize and bind target molecules, including nucleic acids and proteins. Capture moieties applied to the thin-film biosensor surface retain functional stability for more than 1 year at 45°C. Surfaceimmobilized targets can be detected by binding of a labeled detector molecule, such as a biotin-labeled antibody or nucleic acid sequence, followed by binding of an anti-label antibody-HRP conjugate (Fig. 1B) . In the presence of a precipitating substrate for HRP (9 ) , the signal is amplified by deposition of a thin film on the biosensor surface in the vicinity of the capture moiety. The mass contributed by the thin film shifts the reflectance spectrum of light reflected from the surface, producing a visible color change from gold to purple under white light.
Although visual detection of the thin film is a useful feature for rapid, qualitative results, quantitative results are also possible. A charge-coupled device (CCD) image of the biosensor surface can be captured, and the difference in color of the thin-film signal compared with the unreacted surface yields a color difference (CD) value. Under appropriate conditions, CD values are proportional to the concentration of target analyte present (6 ) . CCD imaging is convenient because it uses simple and inexpensive equipment. The CCD imaging system uses a white light source with a diffuser and a 50/50 beam splitter to illuminate the surface uniformly and to allow sufficient light to be reflected into the camera lens. Ellipsometry can also be used to quantify thickness changes on the biosensor surface (10 ).
Materials and Methods reagents
The cytokines interleukin-6 (IL-6), IL1-␤, and interferon-␥ (INF); capture antibodies; biotin-labeled goat anti-human detector antibodies; and streptavidin-HRP were from the DUOSET ELISA development reagent set obtained from R&D Systems. Rabbit anti-goat IgG was obtained from Pierce. Genomic DNA samples were obtained from Coriell Cell Repositories.
surfaces Si 3 N 4 was applied to crystalline silicon wafers in a vapor deposition chamber (Nordiko). The polymer aminoalkyl functional TSPS (UCT) was applied, using a spin coater (Machine Technologies, Inc.), and cured at 150°C for 24 h to produce the thin-film biosensor surface. These surfaces are available under the trade name SILAS at www. thermobiostar.com. The amino-functionalized biosensor was prepared by soaking a SILAS wafer in a 50 mg/L solution of PPL (Sigma) in 1ϫ phosphate-buffered saline (PBS; pH 6) containing 2 mol/L NaCl overnight at room temperature (15 ) . The surface was then washed extensively with H 2 O and 1ϫ PBS, dried under a stream of nitrogen, and stored dry at 4°C.
oligonucleotide synthesis
All DNA oligonucleotides were synthesized by IDT (Coralville, IO) by standard phosphoramidite chemistry. To facilitate detection of the PCR product, the BP1 primer for each of the mutations was terminated with a C 18 biotin phosphoramidite (Glen Research), designated X in the sequence. Primers were as follows:
For exon 10, BP1 was 5Ј-X TCT GTT CTC AGT TTT CCT GG-3Ј, and P2 was 5Ј-TTG GCA TGC TTT GAT GAC GC-3Ј For exon 11, BP1 was 5Ј-X TAG GAC ATC TCC AAG TTT GC-3Ј, and P2 was 5Ј-CAA TAA TTA GTT ATT CAC CTT GC-3Ј For exon 21, BP1 was 5Ј-X TGC TAT AGA AAG TAT TTA TTT TTT CTG G-3Ј, and P2 was 5Ј-AGC CTT ACC TCA TCT GCA AC-3Ј
To facilitate covalent attachment to the surface, all capture sequences were terminated with an amino modifier C 6 phosphoramidite, designated Y in the sequence. Capture sequences were as follows:
For ⌬F508, the wild type was 5Ј-YAC AAC ACC AAA GAT GAT ATT TT-3Ј, and the mutant was 5Ј-YCC GAA ACA CCA ATG ATA TTT TC-3Ј For N1303K, the wild type was 5Ј-YAC GGA TCC AAG TTT TTT CTA A-3Ј, and the mutant was 5Ј-YAC GGA TCC AAC TTT TTT CTA A-3Ј For G551D, the wild type was 5Ј-YAA CTC GTT GAC CTC CAC TC-3Ј, and the mutant was 5Ј-YAA CTC GTT GAT CTC CAC TC-3Ј For G542X, the wild type was 5Ј-YAA CAC CTT CTC CAA GAA CTA TA-3Ј, and the mutant was 5Ј-XAA CAC CTT CTC AAA GAA CTA TA-3Ј
antibody immobilization
Capture antibodies were diluted to 2 mg/L in 0.1 mol/L sodium bicarbonate buffer, pH 9.3, and 200 nL was spotted using a Hamilton MP2200 pipetting robot equipped with a modified dispense head. The antibodies were incubated in a humid chamber for 1 h at room temperature and then allowed to dry. Surfaces were washed with H 2 O and dried under nitrogen. Surfaces were then dip-coated with a preservative solution (ThermoBioStar) and dried.
capture probe immobilization Capture probes were dried and resuspended in 5 L of 0.1 mol/L triethylammonium acetate, pH 7.8. Disuccinimidyl suberate (Pierce) was dissolved to 28 g/L in dimethyl formamide (Aldrich), and 22 L was added to the capture probe and incubated at room temperature for 10 min. 
multiplex reverse transcription-pcr
Genomic DNA targets were amplified in a 50-L multiplex PCR reaction using Qiagen HotStarTaq Master Mix (Qiagen 
Results

cytokine detection array
Because many cytokines have overlapping biological functions, are modulated depending on cell status, and regulate each other's production, it is often of interest to simultaneously detect multiple cytokines. To analyze cytokines in a multiplex assay, we created an array of monoclonal antibodies that recognize IL-6, IL-1␤, and INF-␥ on the biosensor surface. Each antibody was printed in triplicate 600-m (diameter) spots to create a 3 ϫ 4 array on a 5-mm 2 biosensor chip.
The biosensor was incubated with cytokine mixtures at room temperature for 10 min. Surface-bound cytokines were detected by binding a mixture of biotin-labeled, goat antibodies specific for each of the cytokines in the panel, followed by addition of a streptavidin-HRP conjugate. In the presence of a precipitating substrate formulation containing 3,3Ј,5,5Ј-tetramethylbenzidine, an HRP-catalyzed precipitate was deposited to create a thin-film signal. Total assay time was 40 min. An anti-goat antibody control was included to serve as a positive control for the detection reagents (i.e., the goat anti-cytokine antibodies) and to establish orientation of the array.
To test for nonspecific binding of capture antibodies with the inappropriate cytokine or with detector antibodies, we applied individual cytokines to the array. Binding of individual cytokines showed no cross-reactivity; signal was observed only for the specific binding of a cytokinemonoclonal antibody pair (Fig. 2, A and B) . Upon simultaneous binding of multiple cytokines, specific binding was maintained; no cross-reactivity was observed. Nonspecific binding of cytokines was limited; INF-␥ binding was slightly reduced in the presence of IL1-␤ (Fig. 2, C-E) . CD values were used to establish that the signal-to-noise ratio in this experiment ranged from 15 to 80 (Fig. 3) . The signal-to-noise ratio was defined as the CD value of a reacted spot divided by a background, or unreacted, spot. Variability in this value was related to differences in the extent of specific binding because no nonspecific binding was observed. To assess sensitivity, we tested dilution series of cytokines individually. To maintain a multiplex format, surface-bound cytokines were detected with the mixture of three antibodies specific for each of the cytokines. The data showed specific, saturable binding with a dynamic linear range of two orders of magnitude (data not shown). Lower limits of detection were 4 ng/L for IL-6, 31 ng/L for IL1-␤, and 437 ng/L for INF-␥ as defined with reference to the DUOSET reagent set.
snp discrimination panel
To provide a stringent test for the sequence-specific detection of nucleic acid targets in an array format, we developed a panel for the detection of four mutations in the human CFTR gene. One mutation, ⌬F508, is a 3-bp deletion, whereas the other three, G542X, G551D, and N1303K, are SNPs. Wild-type sequences were printed in the top row, and mutant sequences were printed in a second row (Fig. 4) . Individual chips were fixed into the bottoms of wells in a 96-well microtiter plate. Multiplex PCR was carried out using human cell line DNA of known genotype. To facilitate detection, amplicons were prepared with one biotin-labeled primer pair. One microliter of the PCR product was heat-denatured for 3 min, diluted into 200 L of hybridization buffer, and hybridized to the biosensor array for 5 min. The immobilized complex was then treated with an anti-biotin antibody-HRP conjugate. Addition of a precipitating substrate for HRP caused deposition of a thin film on the surface. Total assay time was 15 min.
Optimization of the input concentrations of capture probes was essential to obtain unambiguous genotype discrimination. The optimized input concentration of each capture probe was determined empirically with known genotype targets. For homozygous targets, specific hybridization ratios were varied to provide maximum signal in the absence of detectable visual noise; probe concentrations were varied to give 1:1 signals for heterozygous samples. Final capture probe relative input concentrations varied from 1:1 to 1:10. With the optimized assay, hybridization of PCR-amplified wild-type DNA to the array produced unambiguous and highly specific signals. No cross-reactivity was observed with the mutant capture probes (Fig. 4A) . Hybridization of homozygous mutant DNA PCR products produced signals only on the appropriate mutant capture probes (Fig. 4, B, D, and F) . Hybridization of PCR product from heterozygous samples produced equivalent signal intensities for both the wildtype and mutant capture probe sets (Fig. 4, C and E) . The signal-to-noise performance based on CD values for both homozygous wild-type and mutant samples was ϳ100 for all four mutations tested (Fig. 5) . This ratio was the practical upper limit for the biosensor because saturating CD values were 1.0 and background CD values were 0.01.
Discussion
We have described a sensitive silicon-based platform for specific detection of nucleic acid or protein targets in a A locator for the capture probes specific for the four interrogated mutations is shown. CCD images from experiments using human DNA of defined genotype, subjected to multiplex PCR, as input to the assay as follows: (A), wild type/wild type; (B), ⌬F508/⌬F508; (C), G542X/wild type; (D), G542X/G542X; (E), G551D/ wild type; (F), G551D/G551D. multiplex array format. In this system, binding of target analytes to surface-immobilized capture probes triggers enzyme-catalyzed deposition of a localized thin film that increases the surface thickness. The increased thickness is detected by a change in the surface color from gold to purple. Assay results can be read visually to generate qualitative results or by a CCD camera or ellipsometer to give quantitative results. The biosensor can be formatted in microscope slide and microtiter well dimensions and is compatible with widely used automated devices, including pipetting robots. Optically coated flow-through membranes have also been configured (11 ) .
Application of multiple capture molecules to each surface requires robotic printing of capture moieties. The biosensor surface is quite hydrophobic (contact angle of 105°), making it compatible with the application of capture probes in high densities. Previous work with commercial printing devices has shown that arrays can be produced with a spot diameter of 150 m and a centerto-center spacing of 200 m (data not shown), suggesting that immobilization of capture molecules in densities at least as high as glass substrates is possible (12 ) .
For multiplex cytokine detection, we demonstrated, in a 40-min assay, limits of detection that are similar to those reported for a single analyte/well ELISA format that takes several hours to complete (13 ) . Equivalent assay performance in a shorter assay time may be achieved because the thin-film biosensor signal is confined to a two-dimensional assay instead of being distributed in a threedimensional volume (14 ) . Because of the sensitive color response of the thin-film biosensor to small thickness changes of the surface, relatively few binding events can be transduced by the turnover of HRP into a detectable thin film, reducing assay time.
An important feature for sensitive and specific detection of target analytes in a multiplex format is a high signal-to-noise ratio. The observed specificity of the thinfilm biosensor may be attributable to its chemical simplicity: the surface has limited chemical reactivity and low surface roughness. Analysis of the surface by atomic force microscopy has indicated Ͻ1 nm variance in thickness (data not shown). Application of target nucleic acids or proteins to the biosensor surface in the presence of clinical samples, including whole blood, serum, sputum, and feces, has shown no adverse effect on assay performance (3-7 ) .
The ability to distinguish between single-nucleotide base changes without instrumentation may have applications in various settings where relatively few markers are assessed and/or resources are limited. At present, ϳ100 000 copies of target are required for an easily detectable signal (6 ) . Target amplification allows for very short hybridization times and a rapid overall assay. Further improvements in detection may obviate the need for amplification of human genomic DNA targets.
The detection system described here is suitable for rapid and inexpensive multitarget detection in clinical samples. The material costs of the silicon substrate and the detector (ellipsometer or CCD camera) are low. Furthermore, the detection of multiple targets on the same surface reduces sample reagent usage per test. The format can potentially increase clinical diagnostic throughput in multitarget analysis for such applications as infectious disease panels, antibiotic resistance panels, cancer marker panels, or allelic discrimination of disease-associated markers.
